188 related articles for article (PubMed ID: 25866399)
1. Recombinant, truncated B. circulans keratanase-II: Description and characterisation of a novel enzyme for use in measuring urinary keratan sulphate levels via LC-MS/MS in Morquio A syndrome.
Steward M; Berezovskaya Y; Zhou H; Shediac R; Sun C; Miller N; Rendle PM
Clin Biochem; 2015 Aug; 48(12):796-802. PubMed ID: 25866399
[TBL] [Abstract][Full Text] [Related]
2. Validation of an LC-MS/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio A syndrome.
Martell LA; Cunico RL; Ohh J; Fulkerson W; Furneaux R; Foehr ED
Bioanalysis; 2011 Aug; 3(16):1855-66. PubMed ID: 21877895
[TBL] [Abstract][Full Text] [Related]
3. Construction and functional characterization of truncated versions of recombinant keratanase II from Bacillus circulans.
Wang H; He W; Jiang P; Yu Y; Lin L; Sun X; Koffas M; Zhang F; Linhardt RJ
Glycoconj J; 2017 Oct; 34(5):643-649. PubMed ID: 28752383
[TBL] [Abstract][Full Text] [Related]
4. Purification, characterization, and molecular cloning of a novel keratan sulfate hydrolase, endo-beta-N-acetylglucosaminidase, from Bacillus circulans.
Yamagishi K; Suzuki K; Imai K; Mochizuki H; Morikawa K; Kyogashima M; Kimata K; Watanabe H
J Biol Chem; 2003 Jul; 278(28):25766-72. PubMed ID: 12732618
[TBL] [Abstract][Full Text] [Related]
5. Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry.
Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; de Carvalho TG; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Kida K; Kubota M; Barrera L; Orii T
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S35-42. PubMed ID: 20107903
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of urinary keratan sulfate disaccharides in MPS IVA patients using UPLC-MS/MS.
Auray-Blais C; Lavoie P; Maranda B; Boutin M
Bioanalysis; 2016 Feb; 8(3):179-91. PubMed ID: 26805456
[TBL] [Abstract][Full Text] [Related]
7. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.
Dũng VC; Tomatsu S; Montaño AM; Gottesman G; Bober MB; Mackenzie W; Maeda M; Mitchell GA; Suzuki Y; Orii T
Mol Genet Metab; 2013; 110(1-2):129-38. PubMed ID: 23876334
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of
Cameron SA; Zubkova OV; Toms S; Furneaux RH; Rendle PM
J Labelled Comp Radiopharm; 2019 Feb; 62(2):67-76. PubMed ID: 30548247
[TBL] [Abstract][Full Text] [Related]
9. UPLC–MS/MS analysis of keratan sulfate from urine samples collected on filter paper for monitoring & follow-up of Morquio A patients.
Auray-Blais C; Collerette-Tremblay J; Lavoie P
Bioanalysis; 2018 Aug; 10(15):1181-1192. PubMed ID: 30059256
[TBL] [Abstract][Full Text] [Related]
10. Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.
Sawamoto K; Tomatsu S
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450640
[TBL] [Abstract][Full Text] [Related]
11. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
[TBL] [Abstract][Full Text] [Related]
12. Elosulfase Alfa: a review of its use in patients with mucopolysaccharidosis type IVA (Morquio A syndrome).
Lyseng-Williamson KA
BioDrugs; 2014 Oct; 28(5):465-75. PubMed ID: 25200032
[TBL] [Abstract][Full Text] [Related]
13. Practical and reliable enzyme test for the detection of mucopolysaccharidosis IVA (Morquio Syndrome type A) in dried blood samples.
Camelier MV; Burin MG; De Mari J; Vieira TA; Marasca G; Giugliani R
Clin Chim Acta; 2011 Sep; 412(19-20):1805-8. PubMed ID: 21684269
[TBL] [Abstract][Full Text] [Related]
14. Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA.
Tomatsu S; Okamura K; Taketani T; Orii KO; Nishioka T; Gutierrez MA; Velez-Castrillon S; Fachel AA; Grubb JH; Cooper A; Thornley M; Wraith E; Barrera LA; Giugliani R; Schwartz IV; Frenking GS; Beck M; Kircher SG; Paschke E; Yamaguchi S; Ullrich K; Isogai K; Suzuki Y; Orii T; Kondo N; Creer M; Noguchi A
Pediatr Res; 2004 Apr; 55(4):592-7. PubMed ID: 14711889
[TBL] [Abstract][Full Text] [Related]
15. [Mucopolysaccharidosis IVA (Morquio A syndrome): clinical, biological and therapeutic aspects].
Bouzidi H; Khedhiri S; Laradi S; Ferchichi S; Daudon M; Miled A
Ann Biol Clin (Paris); 2007; 65(1):5-11. PubMed ID: 17264033
[TBL] [Abstract][Full Text] [Related]
16. Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.
Dvorak-Ewell M; Wendt D; Hague C; Christianson T; Koppaka V; Crippen D; Kakkis E; Vellard M
PLoS One; 2010 Aug; 5(8):e12194. PubMed ID: 20808938
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of Morquio Syndrome in Dried Blood Spots Based on a New MRM-MS Assay.
Cozma C; Eichler S; Wittmann G; Flores Bonet A; Kramp GJ; Giese AK; Rolfs A
PLoS One; 2015; 10(7):e0131228. PubMed ID: 26147980
[TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement therapy in a murine model of Morquio A syndrome.
Tomatsu S; Montaño AM; Ohashi A; Gutierrez MA; Oikawa H; Oguma T; Dung VC; Nishioka T; Orii T; Sly WS
Hum Mol Genet; 2008 Mar; 17(6):815-24. PubMed ID: 18056156
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial.
Schweighardt B; Tompkins T; Lau K; Jesaitis L; Qi Y; Musson DG; Farmer P; Haller C; Shaywitz AJ; Yang K; O'Neill CA
Clin Ther; 2015 May; 37(5):1012-1021.e6. PubMed ID: 25487082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
